SC 13D

Company

Emergent BioSolutions Inc.

Filed

August 23, 2010

Accession Number

0000950123-10-079964

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →